Mateo has over 20 years of experience with (bio)medical companies. For the last fifteen years, he worked for Agilent Technologies, as Associate Vice President EMEAI. His proven leadership capabilities and marketing & sales experience will be a massive benefit in this new role.
Focus on people and culture
The new Vice President is honoured and thrilled of his appointment and has a clear vision: 'I believe in the employees of Sakura. They are the key to the strong brand Sakura Finetek Europe is today. I will focus on extending our solid culture of innovation, teamwork, and customer centricity to be able to empower pathology professionals, now and in the future.'
Chris Koeman, General Manager at Sakura Finetek Europe: 'We look forward working together with Mateo. We believe he has the experience and drive to enable the ambitious plans Sakura has. His progressive and human approach is what makes him the ideal candidate to help us bring Sakura to the next level.'
More about Sakura Finetek Europe
At Sakura Finetek Europe we advance cancer diagnostics by providing integrated solutions for anatomic pathology and patients through best-in-class innovations, quality and customer care. This is how Sakura became the original manufacturer of Tissue-Tek®, Cyto-Tek®, Tissue-Tek VIP® and Tissue-Tek Xpress®, today’s industry standards. With headquarters based in Alphen aan den Rijn (NL) and seven regional locations in Europe we empower pathology professionals in the whole EMEAI region. For more information visit www.sakura.eu, follow us on LinkedIn.